Infectious DiseasesHematologyConference1 CME hours

International Symposium on Vaccine Safety, Infectious Diseases and Immunology (ISVSI-27)

Name: International Symposium on Vaccine Safety, Infectious Diseases and Immunology (ISVSI-27)
Start: 2027-05-10T06:00:00.000Z
End: 2027-05-11T14:00:00.000Z
Location: Riyadh , Saudi Arabia.

Organised by ISRD

Date10–11 May · 09:00 – 17:00

VenueRiyadh , Saudi Arabia.

AccreditationSCFHS · 1 hrs

10–11 May 2027

09:00 – 17:00 daily

Riyadh , Saudi Arabia.

Riyadh

1 CME hrs

SCFHS

International Symposium on Vaccine Safety, Infectious Diseases and Immunology (ISVSI-27)

View full poster

About the event

• Vaccine Safety & Pharmacovigilance: Analyzing post-market surveillance systems, adverse event reporting data, and statistical methods used to ensure vaccine safety across global populations. • Adjuvant & Formulation Breakthroughs: Discovering new delivery mechanisms and chemical adjuvants designed to enhance target immunogenicity while minimizing side effects. • Immunological Tolerance & Memory: Evaluating host immune responses to vaccines, long-term antibody persistence, and cell-mediated immunity variations across different age groups. • Regulatory Frameworks & Ethical Approval: Understanding updated global regulatory compliance paths, clinical trial ethics, and policies governing emergency use authorizations for novel vaccines.

Agenda and speakers are for members

AccreditationSCFHS · 1 hours

Target audience• Pharmacovigilance & Safety Experts: Specialists tasked with monitoring clinical trial safety data, tracking post-market adverse events, and assessing vaccine risk-benefit profiles. • Vaccine Manufacturers & Formulation Scientists: Pharmaceutical industry researchers developing novel adjuvants, delivery platforms (like mRNA or viral vectors), and stabilizing agents. • Immunologists & Serologists: Academics and lab scientists investigating long-term immune memory, cellular defense mechanisms, and antibody responses to vaccination. • Regulatory Affairs Officials & Policymakers: Government health representatives (such as the FDA, EMA, or WHO counterparts) who evaluate clinical data for vaccine approvals and public distribution policies. • Clinical Trial Coordinators & Clinicians: Physicians, nurses, and principal investigators managing human trials, patient screening, and ethical compliance protocols.

Members go straight to the organiser’s registration page.

SAR 5,600

Date & time10–11 May 2027 · 09:00 – 17:00

VenueRiyadh , Saudi Arabia., Riyadh

AccreditationSCFHS · 1 hours

Members go straight to the organiser’s registration page

SAR 5,600